Can 1/1 atrial flutter be prevented by class 1 anti-arrhythmics;Peut-on prevoir le flutter 1/1 sous antiarythmiques de classe I?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue 7, 1997, Pages 961-966

  Brembilla Perrot, B ^a   Terrier de la Chaise, A ^a   Jacquemin, L ^a   Beurrier, D ^a   Houplon, P ^a   Louis, P ^a   Danchin, N ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Antiarythmiques de classe I; Electrocardiogramme a haute amplification; Flutter << quinidinique >>; PR court

Indexed keywords

ANTIARRHYTHMIC AGENT; CIBENZOLINE; DIHYDROQUINIDINE; DISOPYRAMIDE; FLECAINIDE; PROPAFENONE; QUINIDINE; IMIDAZOLE DERIVATIVE;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HEART ATRIUM FLUTTER; HEART ATRIUM HYPERTROPHY; HEART LEFT ATRIUM; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; P WAVE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PR INTERVAL; QRS COMPLEX; VALVULAR HEART DISEASE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; DISOPYRAMIDE; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HEART CONDUCTION SYSTEM; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPAFENONE; QUINIDINE; RISK FACTORS;

EID: 0031179552     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB. Aggravation and provocation of ventricular arrythmias by antiarrhythmic drugs. Circulation 1982 ; 65 : 886-94.
2. Craemer JE, Nathan AW, Camm AJ. The proarrhythmic effects of antiarrhythmic drugs. Am Heart J 1987 ; 114 : 397-406.
3. Kerin NS, Somberg J. Proarrhythmia : definition, risk factors, causes, treatment and controversies. Am Heart J 1994 ; 126 : 575-85.
4. Fillette F, Dupuis BA, Grosgogeat Y. Les effets arhythmogènes des antiarhythmiques. Arch Mal Cæur 1986 ; 79 : 1532-4.
5. Torres V, Flowers D, Somberg JC. The arrhythmogenicity of antiarrhythmic agents. Am Heart J 1985 ; 109 : 1090-4.
6. CAST investigators. Preliminary report : effect of encaïnide on mortality in a randomized-trial of arrhythmia suppression after myocardial infarction. New Engl J Med 1989; 321 : 406-12.
7. London F, Howell M. Atrial flutter : 1 to 1 conduction during treatment with quinidine and digitalis. Am Heart J 1954 ; 48 : 152-6.
8. Robertson CE, Miller HC. Extreme tachycardia complicating the use of disopyramide in atrial flutter. Br Heart J 1980 ; 44 : 602-3.
9. Crijns HJ, Van Gelder IC, Lie KI. Supraventricular lachycadia mimicking ventricular tachycardia during flecaïnide treatment. Am J Cardiol 1988 ; 62 : 1303-6.
10. Murdock CJ, Kyles AE, Yeung-Lai-Wah JA et al. Atrial flutter in patient treatment for atrial fibrillation with propafenone. Am J Cardiol 1990; 66 : 775-7.
11. Feld GK, Chen PS, Nicod P, Fleck P, Meyer D. Possible atrial proarrhythmic effects of class I c antiarrnythmic drugs. Am J Cardiol 1990 ; 66 : 378-83.
12. Weimer HL, McCarthy EA, Pritchett ELC. Regular ventricular rhythm in patients witn symptomatic paroxysmal atrial fibrillation. J Am Coll Cardiol 1991 ; 17 : 1283-7.
13. Fauchier JP, Babuty D, Fauchier L, Rouesnel P, Cosnay P. Les effets pro-arythmiques des antiarythmiques. Arch Mal Cæur 1992; 85 : 891-7.
14. Aouate P, Franck R, Fontaine G et al. Tachycardie supraventriculaire à QRS larges survenant sous antiarythmique de la classe I de Vaughan-Williams. Implacations diagnostiques et thérapeutiques. Arch Mal Cæur 1995 ; 88 : 1869-74.
15. Estes NAM, Garan H, Ruskin JN. Electrophysiologic properties of flecaïnide acetate. Am J Cardiol 1984 ; 53 : B 26-B 29.
16. Alboni P, Paparello N, Cappato R, Candini GC. Direct and antonomically mediated effects of oral flecaïnide. Am J Cardiol 1986 ; 61 : 759-63.
17. Chauvin M, Brechenmacher C. Électrocardiogramme moyenné de l'onde P après réduction d'une fibrillation auriculaire permanente. Comparaisons avec les résultats obtenus chez des sujets sains ou victimes de fibrillation auriculaire paroxystique. Arch Mal Cæur 1993 ; 86 : 1483-8.
18. Fukunami M, Yamada T, Ohmori M et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave triggered signal-averaged electrocardiogram. Circulation 1991 ; 83 : 162-9.
19. Yamada T, Fukunami M, Ohmori M et al. Characteristics of frequency content of atrial signal-averaged electrocardiograms during sinus rhythm in patients with paroxysmal atrial fibriliation. J Am Coll Cardiol 1992 ; 19 : 559-63.